References
1. Stewart, E., Cookson, C., Gandolfo, R. and Schulze-Rath, R., 2017. Epidemiology of uterine fibroids: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology, 124(10), pp.1501-1512.
2. Royal College of Obstetricians &amp; Gynaecologists. 2022. Fibroids. [online] Available at: <https://www.rcog.org.uk/en/patients/fertility/female-problems/fibroids/> [Accessed 19 January 2022].
3. Younas, K., Hadoura, E., Majoko, F. and Bunkheila, A., 2016. A review of evidence-based management of uterine fibroids. The Obstetrician & Gynaecologist, 18(1), pp.33-42.
4. BMJ Best Practice. 2022. Uterine fibroids- treatment algorithm. [online] Available at: <https://bestpractice.bmj.com/topics/en-gb/567/treatment-algorithm> [Accessed 19 January 2022].
5. Vercellini, P., Giorgio Crosignani, P., Mangioni, C., Imparato, E., Ferrari, A. and Giorgi, O., 1998. Treatment with a gonadotrophin releasing hormone agonist before hysterectomy for leiomyomas: results of a multicentre, randomised controlled trial. BJOG: An International Journal of Obstetrics & Gynaecology, 105(11), pp.1148-1154.
6. Rcog.org.uk. 2013. Clinical recommendations on the use of UAE in the management of fibroids. [online] Available at: <https://www.rcog.org.uk/globalassets/documents/guidelines/23-12-2013_rcog_rcr_uae.pdf> [Accessed 19 January 2022].
7. Hehenkamp, W., Volkers, N., Donderwinkel, P., de Blok, S., Birnie, E., Ankum, W. and Reekers, J., 2005. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri- and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology, 193(5), pp.1618-1629.
8. Pinto, I., Chimeno, P., Romo, A., Paúl, L., Haya, J., de la Cal, M. et al., 2003. Uterine Fibroids: Uterine Artery Embolization versus Abdominal Hysterectomy for Treatment—A Prospective, Randomized, and Controlled Clinical Trial. Radiology, 226(2), pp.425-431.
9. Ruuskanen, A., Hippeläinen, M., Sipola, P. and Manninen, H., 2010. Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2-year follow-up results of a randomised prospective clinical trial. European Radiology, 20(10), pp.2524-2532.
10. Moss, J., Cooper, K., Khaund, A., Murray, L., Murray, G., Wu, O., et al., 2011. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG: An International Journal of Obstetrics & Gynaecology, 118(8), pp.936-944.
11. Jun, F., Yamin, L., Xinli, X., Zhe, L., Min, Z., Bo, Z. et al., 2011. Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta-analysis of the literature. Archives of Gynecology and Obstetrics, 285(5), pp.1407-1413.
12. Fonseca, M., Castro, R., Machado, M., Conte, T. and Girao, M., 2017. Uterine Artery Embolization and Surgical Methods for the Treatment of Symptomatic Uterine Leiomyomas: A Systemic Review and Meta-analysis Followed by Indirect Treatment Comparison. Clinical Therapeutics, 39(7), pp.1438-1455.e2.
13. Havryliuk, Y., Setton, R., Carlow, J. and Shaktman, B., 2017. Symptomatic Fibroid Management: Systematic Review of the Literature. JSLS : Journal of the Society of Laparoendoscopic Surgeons, 21(3), pp.e2017.00041.
14. Manyonda, I., Bratby, M., Horst, J., Banu, N., Gorti, M. and Belli, A., 2011. Uterine Artery Embolization versus Myomectomy: Impact on Quality of Life—Results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial. CardioVascular and Interventional Radiology, 35(3), pp.530-536. 15. Mara, M., Maskova, J., Fucikova, Z., Kuzel, D., Belsan, T. and Sosna, O., 2007. Midterm Clinical and First Reproductive Results of a Randomized Controlled Trial Comparing Uterine Fibroid Embolization and Myomectomy. CardioVascular and Interventional Radiology, 31(1), pp.73-85.
16. Manyonda, I., Belli, A., Lumsden, M., Moss, J., McKinnon, W., Middleton, L., et al., 2020. Uterine-Artery Embolization or Myomectomy for Uterine Fibroids. New England Journal of Medicine, 383(5), pp.440-451.
17. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 2021;372:n160. doi: 10.1136/bmj.n160
18. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al., 2013.The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
19. Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y., et al., 2019. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ; 366: l4898.
20. Review Manager (RevMan) [Computer program] (2020). The Cochrane Collaboration. Version 5.4.
21. Edwards, R., Moss, J., Lumsden, M., Wu, O., Murray, L., Twaddle, S., et al., 2007. Uterine-Artery Embolization versus Surgery for Symptomatic Uterine Fibroids. New England Journal of Medicine, 356(4), pp.360-370.
22. Ananthakrishnan, G., Murray, L., Ritchie, M., Murray, G., Bryden, F., Lassman, S., et al., 2012. Randomized Comparison of Uterine Artery Embolization (UAE) with Surgical Treatment in Patients with Symptomatic Uterine Fibroids (REST Trial): Subanalysis of 5-Year MRI Findings. CardioVascular and Interventional Radiology, 36(3), pp.676-681.
23. Gupta, J., Sinha, A., Lumsden, M. and Hickey, M., 2012. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database of Systematic Reviews,.
24. Van der Kooij, S., Bipat, S., Hehenkamp, W., Ankum, W., Reekers, J., 2011. Uterine artery embolization versus surgery in the treatment of symptomatic fibroids: a systematic review and metaanalysis. American Journal of Obstetrics and Gynecology, 205(4), pp.317.e1-317.e18.
25. Tang, S., Kong, M., Zhao, X., Chen, J., Wang, C., Zhang, H., et al., 2018. A systematic review and meta-analysis of the safety and efficacy of uterine artery embolization vs. surgery for symptomatic uterine fibroids. Journal of Interventional Medicine, 1(2), pp.112-120.
26. Narayan, A., Lee, A., Kuo, G., Powe, N. and Kim, H., 2010. Uterine Artery Embolization versus Abdominal Myomectomy: A Long-term Clinical Outcome Comparison. Journal of Vascular and Interventional Radiology, 21(7), pp.1011-1017.
27. Razavi, M., Hwang, G., Jahed, A., Modanloo, S. and Chen, B., 2003. Abdominal Myomectomy Versus Uterine Fibroid Embolization in the Treatment of Symptomatic Uterine Leiomyomas. American Journal of Roentgenology, 180(6), pp.1571-1575.
28. Siskin, G., Shlansky-Goldberg, R., Goodwin, S., Sterling, K., Lipman, J., Nosher, J., et al., A Prospective Multicenter Comparative Study between Myomectomy and Uterine Artery Embolization with Polyvinyl Alcohol Microspheres: Long-term Clinical Outcomes in Patients with Symptomatic Uterine Fibroids. Journal of Vascular and Interventional Radiology, 17(8), pp.1287-1295.
29. Goodwin, S., Bradley, L., Lipman, J., Stewart, E., Nosher, J., Sterling, K., et al., 2006. Uterine artery embolization versus myomectomy: a multicenter comparative study. Fertility and Sterility, 85(1), pp.14-21.
30. Broder, M., Goodwin, S., Chen, G., Tang, LJ., Costantino, MM., Nguyen, MH et al., 2002. Comparison of long-term outcomes of myomectomy and uterine artery embolization. Obstetrics & Gynecology, 100(5), pp.864-868.
31. Spies JB, Warren EH, Mathias SD, Walsh SM, Roth AR, Pentecost MJ. 1999. Uterine fibroid embolization: measurement of health related quality of life before and after therapy. J Vasc Interv Radiol;10:1293–303.